This document is a clinical practice guideline (CPG) on the management of idiopathic pulmonary fibrosis (IPF) in Tunisia, developed jointly by STMRA and INEAS. 

It presents evidence-based recommendations adapted to the Tunisian context, covering diagnosis, initial workup, treatment (notably with nintedanib), follow-up, and management of comorbidities. The methodology used to develop the CPG, including bibliographic research and adaptation of international guidelines, is detailed. 

The guide includes recommendations graded according to the level of evidence, and includes tables and figures to illustrate the clinical, radiological and histopathological aspects of IPF.


New tracks tagged #Clinical Practice Guideline